Reports record revenue of $19.5 million for the first quarter of 2025, an increase of $1.9 million or 11%, compared to the same period in 2024. Reports GAAP diluted EPS of $0.37 and non-GAAP diluted ...

The global market for MRI compatible patient monitoring systems is set to achieve remarkable growth over the next decade, driven by advancements in medical technology and the rising adoption of MRI ...

Overview: IRADIMED CORPORATION specializes in the development, manufacturing, marketing, and distribution of MRI-compatible ... from its patient monitoring equipment segment, which accounts ...

Imricor, Clever Culture Systems and Race Oncology are among ASX health companies reporting strong quarterly results this week.

Furthermore, the company's cash flow from operations for the first quarter of 2025 was $4.3 million, reflecting a 10% ...

"After a while, I forgot that I was doing a remote surgery," Cleveland Clinic urologist Dr. Ruben Olivares said of EDAP's ...

Power's pick of the week is Imricor Medical Systems (ASX:IMR), which has kicked off the start ... Imricor has developed the only MRI-compatible consumable devices, such as single-use ablation ...

Power’s Powerplay: Imricor achieves world first Power’s pick of the week is Imricor Medical Systems (ASX:IMR), which has kicked ... Imricor has developed the only MRI-compatible consumable devices, ...

A medical team at the Amsterdam University Medical Centre (AUMC) in the Netherlands completed the first-in-human ventricular ...

IRMD's unique MRI-compatible IV infusion pump and patient monitoring system face limited competition, ensuring a strong market position. Financials show robust performance with a 21% increase in ...